EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Experimental Models to Investigate PNPLA3 in Liver Steatosis

Alireza Ramandi iD, Anna-Mae Diehl, Arun J Sanyal iD, Ype P de Jong iD

Liver International · 2025

DOI: 10.1111/liv.70091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Liver International, 2025. Verfasst von Alireza Ramandi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Lipase, Fatty Liver, Membrane Proteins, Phospholipases A2, Calcium-Independent. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patatin‐like phospholipase domain‐containing 3 (PNPLA3) was the first gene identified through genome‐wide association studies to be linked to hepatic fat accumulation. A missense variant, encoding the PNPLA3‐148M allele, has since been shown to increase the risk for the full spectrum of steatotic liver disease (SLD), from simple steatosis to steatohepatitis, cirrhosis, and hepatocellular carcinoma. Despite extensive validation of this association and ongoing research into its pathogenic role, the precise mechanisms by which PNPLA3‐148M contributes to the progression of SLD remain poorly understood. In this review, we evaluate preclinical in vitro and in vivo models used to investigate PNPLA3 and its involvement in SLD, with particular emphasis on metabolic dysfunction‐associated steatotic liver disease. We assess the strengths and limitations of these models, as well as the challenges arising from species differences in PNPLA3 expression and function between human and murine systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipaseFatty LiverMembrane ProteinsPhospholipases A2, Calcium-IndependentHumansAnimalsDisease Models, AnimalMiceLiverNon-alcoholic Fatty Liver DiseaseGenetic Predisposition to DiseaseMutation, MissenseAcyltransferases

Stichwörter der Autor:innen

MASHMASLDNAFLDfatty livermouse

Substanzen

PNPLA3 protein, humanLipaseMembrane ProteinsPhospholipases A2, Calcium-IndependentAcyltransferases

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, New York, USA.
  • Department of Medicine, Duke University, Durham, North Carolina, USA.
  • Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University, Richmond, Virginia, USA.

ORCID-Profile: Alireza Ramandi, Arun J Sanyal, Ype P de Jong

Förderung

  • NHLBI NIH HHS
  • NIAAA NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Ramandi, A., Diehl, A. M., Sanyal, A. J., & de Jong, Y. P. (2025). Experimental Models to Investigate PNPLA3 in Liver Steatosis. Liver International. https://doi.org/10.1111/liv.70091

Vancouver

Ramandi A, Diehl AM, Sanyal AJ, de Jong YP. Experimental Models to Investigate PNPLA3 in Liver Steatosis. Liver International. 2025. doi:10.1111/liv.70091

BibTeX
@article{Ramandi2025,
  author = {Ramandi, Alireza and Diehl, Anna-Mae and Sanyal, Arun J and de Jong, Ype P},
  title = {Experimental Models to Investigate PNPLA3 in Liver Steatosis},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70091}
}
Kostenlos starten →